Optimer's Dificid paves path for orals with CMS NTAP status
01:50 EDT 3 Aug 2012 | SCRIP
It took investors a few hours on 2 August to catch on to the significance of the win Optimer Pharmaceuticals scored with the US Centers for Medicare & Medicaid Services (CMS) in nabbing a new technology add-on payment (NTAP) designation.....
Original Article: Optimer's Dificid paves path for orals with CMS NTAP status
More From BioPortfolio on "Optimer's Dificid paves path for orals with CMS NTAP status"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
